Mechanism of Radiosensitization by Inhibitors of Poly (ADP-Ribose) Polymerase (PARP)

被引：1
|
作者：
Glazer, P. M. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.234
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [41] Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors
    Guha, Mausumee
    Sobol, Zhanna
    Martin, Mathew
    Hemkens, Michelle
    Sung, Tae
    Rubitski, Elizabeth
    Spellman, Richard
    Finkelstein, Martin
    Khan, Nasir
    Hu, Wenyue
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (06) : 442 - 454
  • [42] Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment
    Mason, Kathryn A.
    Raju, Uma
    Buchholz, Thomas A.
    Wang, Li
    Milas, Zvonimir L.
    Milas, Luka
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 90 - 100
  • [43] The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
    Virág, L
    Szabó, C
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (03) : 375 - 429
  • [44] Poly(ADP-ribose) polymerase (PARP) inhibition and cytoprotection using novel, potent isoindolinone-inhibitors of PARP
    Baloglu, E
    Jagtap, P
    Mabley, JG
    Salzman, AL
    Szabo, C
    Southan, GJ
    [J]. FASEB JOURNAL, 2003, 17 (05): : A1360 - A1360
  • [45] The Inhibition and Treatment of Breast Cancer with Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors
    De Soto, Joseph A.
    Wang, Xianyan
    Tominaga, Yohei
    Wang, Rui-Hong
    Cao, Liu
    Qiao, Wenhui
    Li, Cuiling
    Xu, Xiaoling
    Skoumbourdis, Amanda P.
    Prindiville, Sheila A.
    Thomas, Craig J.
    Deng, Chu-Xia
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2006, 2 (04): : 179 - 185
  • [46] A yeast growth assay to characterize plant poly(ADP-ribose) polymerase (PARP) proteins and inhibitors
    Rissel, Dagmar
    Heym, Peter Paul
    Peiter, Edgar
    [J]. ANALYTICAL BIOCHEMISTRY, 2017, 527 : 20 - 23
  • [47] NOVEL POTENT INHIBITORS OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE)POLYMERASE (PARP)
    GRIFFIN, RJ
    PEMBERTON, LC
    RHODES, D
    BLEASDALE, C
    BOWMAN, K
    CALVERT, AH
    CURTIN, NJ
    DURKACZ, BW
    NEWELL, DR
    PORTEOUS, JK
    GOLDING, BT
    [J]. ANTI-CANCER DRUG DESIGN, 1995, 10 (06): : 507 - 514
  • [48] Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer
    Desnoyers, A.
    Nadler, M.
    Wilson, B. E.
    Stajer, S.
    Amir, E.
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [49] Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors
    Gupta, Shruti
    Hanna, Paul E.
    Ouyang, Tianqi
    Yamada, Karla Sofia
    Sawtell, Rani
    Wang, Qiyu
    Katz-Agranov, Nurit
    Feghali, Lea
    Krasner, Carolyn N.
    Bouberhan, Sara
    Castro, Cesar M.
    Sise, Meghan E.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (07) : 831 - 837
  • [50] Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy
    Cepeda, Victoria
    Fuertes, Miguel A.
    Castilla, Josefina
    Alonso, Carlos
    Quevedo, Celia
    Soto, Manual
    Perez, Jose M.
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2006, 1 (01) : 39 - 53
12345